Hospital Findr / Find Doctors / Connecticut / Dr. Joseph Rosenblatt

Dr. Joseph Rosenblatt, MD

Endocrinology, Diabetes & Metabolism, Internal Medicine
48 years of experience
Starling Physicians 300 Kensington Ave, New Britain, CT 06051
(860) 224-6266

Overview
Location
Expertise
Insurance

Brief Intro

Joseph D. Rosenblatt, M.D., is a Professor of Medicine, Chief of Hematology and Oncology and Associate Director for Clinical and Translational Research for the Sylvester Comprehensive Cancer Center (SCCC) at the University of Miami (UM). He holds a graduate cross appointment in the Department of Microbiology and Immunology at UM. Dr. Rosenblatt is also a member of the Tumor Immunology Program. In the past 20 years, Dr. Rosenblatt has published over 100 journal articles and chapters in the areas of human retroviruses, immune therapies for cancer, and human gene therapy. Dr. Rosenblatt's work has general relevance to breast cancer and he has held major breast cancer grant funding in the past. Prior to his move to Miami, Dr. Rosenblatt served as Chief of the Hematology-Oncology Unit, and had a secondary appointment within the Department of Microbiology and Immunology at the University of Rochester from 1995-2001. Prior to 1995, Dr. Rosenblatt had been a member of the faculty in Hematology Oncology (Associate Professor) and was elected an Associate Member of the Molecular Biology Institute at UCLA, California. Dr Rosenblatt joined University of Miami in 2001, bringing extensive administrative and research experience. He has had continuous NIH and other extramural funding for retroviral, gene therapy and immunotherapy related research since 1986 and has been a standing member of the NCI Experimental Therapeutics II (ET-2) and currently the Clinical Immunology and Immunotherapy II (C-II) study sections. As a Clinician Scientist, his mentorship is of particular importance as SCCC scientist seek to enhance cross talk between our post-PhD and post-MD Fellows in this Breast Cancer Translational Research. His research relevant to Breast Cancer includes the synthesis and testing of novel antibodyfusion proteins which target the HER2 breast cancer antigen, and can inhibit angiogenesis or augment immune response to breast cancer.

Education Background

RESIDENCY

Deaconess Hospital

MEDICAL SCHOOL

University Of Connecticut School Of Medicine - 1977

Languages Spoken

Spanish
Polish

Location & Hours

Starling Physicians
300 Kensington Ave, New Britain, CT 06051
Mon:9:00 am - 5:00 pm
Tue:9:00 am - 5:00 pm
Wed:9:00 am - 5:00 pm
Thu:9:00 am - 5:00 pm
Fri:9:00 am - 5:00 pm
Sat:Closed
Sun:Closed

Specialties Treated

Endocrinology, Diabetes & Metabolism
Internal Medicine

Conditions Addressed

Hypoparathyroidism
Thyroid Cancer
Hypothyroidism
Diabetic Peripheral Neuropathy
Thyroiditis
Diabetes Mellitus (DM)
Disorders of Lipoid Metabolism
Non-Toxic Goiter
Hyperthyroidism

Insurance Accepted

* Insurance information may change frequently. Please verify directly with the provider (doctor/clinic).

ConnectiCare
Aetna
UnitedHealthcare
Humana
Blue Cross Blue Shield
Anthem Blue Cross and Blue Shield Connecticut

Cancer 14
Cardiology, Heart & Vascular Surgery 7
Orthopedics 20
Neurology & Neurosurgery 17
Gastroenterology & GI Surgery 19
Pulmonology & Lung Surgery 21
Diabetes & Endocrinology 10
Children's Hospital 3
Urology 19
Psychiatry 27
Geriatrics 19
Rehabilitation 7
Obsterics & Gynecology 1
Ophthalmology 1
Ear, Nose & Throat 2
Long Term Care 3
Maternity Care (Uncomplicated Pregnancy) 16